Non-small cell lung cancer (nsclc) Clinical Trials
Conditions / Non-small cell lung cancer (nsclc)
Delta Trials records 245 clinical trials for Non-small cell lung cancer (nsclc) in its publicly accessible dataset. From the full dataset, 65 actively seeking eligible participants and 92 trials have reached completion. This research is conducted across 1,592 study locations around the world. An additional 88 trials are active but not currently open for enrollment. Since 2020, 26 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
245
Total Trials
65
Recruiting
92
Completed
88
Other Active
26
Terminated since 2020
1592
Study Locations
Browse by location (1592 total)
- Barcelona, Spain 45 trialsAll trials in Barcelona, Spain
- Madrid, Spain 44 trialsAll trials in Madrid, Spain
- Seoul, South Korea 41 trialsAll trials in Seoul, South Korea
- Nashville, United States 37 trialsAll trials in Nashville, United States
- New York, United States 37 trialsAll trials in New York, United States
- Taipei, Taiwan 35 trialsAll trials in Taipei, Taiwan
- Taipei, Taiwan 35 trialsAll trials in Taipei, Taiwan
- Houston, United States 35 trialsAll trials in Houston, United States
- Fairfax, United States 34 trialsAll trials in Fairfax, United States
- Milan, Italy 28 trialsAll trials in Milan, Italy
- Shanghai, China 28 trialsAll trials in Shanghai, China
- Seville, Spain 26 trialsAll trials in Seville, Spain
- Marseille, France 26 trialsAll trials in Marseille, France
- Beijing, China 25 trialsAll trials in Beijing, China
- London, United Kingdom 25 trialsAll trials in London, United Kingdom
- Guangzhou, China 24 trialsAll trials in Guangzhou, China
- Tainan, Taiwan 24 trialsAll trials in Tainan, Taiwan
- Taichung, Taiwan 23 trialsAll trials in Taichung, Taiwan
- Boston, United States 23 trialsAll trials in Boston, United States
- Los Angeles, United States 23 trialsAll trials in Los Angeles, United States